Communication Issues in Patient and Provider Discussions of Immunotherapy

Emory University

Status: Enrolling

Conditions: Malignant Solid Neoplasm; Hematopoietic and Lymphoid System Neoplasm

Treatments: Other: Educational video; Other: Observation; Other: Interview

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT05873608

P30CA138292 (U.S. NIH Grant/Contract)

P01CA257906 (U.S. NIH Grant/Contract)

WINSHIP3293-16 (Other Identifier)

NCI-2020-00828 (Registry Identifier)

IRB00091198

Details and patient eligibility

About

This trials studies communication issues in patient and provider discussions about immunotherapy. The goal of this study is to describe where patients have heard about immunotherapy, what the participants understand about it, how physicians and other healthcare workers describe immunotherapy, and how educational videos may support patient knowledge about immunotherapy.

Full description

PRIMARY OBJECTIVES:

I. To identify misestimations about the risks and benefits of immunotherapy resulting from media hype or other sources and assess if these misestimations persist post-provider conversation about immunotherapy.

II. To qualitatively describe patient reported misunderstandings and to assess patient understanding of technical terms and metaphors used in the immunotherapy conversation.

III. To identify provider and patient preferences for information to be communicated about immunotherapy.

IV. Develop videos that describe immunotherapy and test their efficacy in improving understanding using pre and post methodology.

OUTLINE:

Patients and their providers undergo observation during a conversation about immunotherapy. Then participate in an interview over 20 minutes. Understanding of educational videos is then tested.

Enrollment: 125 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• AIMS 1-3: All patients and providers who may have a discussion about immunotherapy at the Winship Cancer Institute
• AIM 4: Any cancer patient

Trial design

Primary purpose: Other

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

125 participants in 2 patient groups

Interview

Other group

Description:

Patients and providers undergo observation during a conversation about immunotherapy. Then participate in an interview over 20 minutes.

Treatment:

Other: Interview

Other: Observation

Aim 4 tests an educational video

Other group

Description:

The participants watch a video and their comprehension is tested in a pre and post methodology

Treatment:

Other: Educational video